Tuesday, November 21, 2017 10:15 PM ET
ChromaDex (CDXC) sees Significant Insider buy Extending Trend of purchases over Last Quarter
There was a significant insider purchase in ChromaDex shares today as disclosed in a filing with the SEC. One insider — Champion River Ventures Ltd, 10% Owner — bought 731,707 shares in the company having a net market value of approximately $2,999,999. There was one insider buy/sell transaction in the past 90 days prior to this transaction which resulted in the purchase of 2,000 shares. Adding the most recent activity to this 90-day history indicates insider trades have been net purchases of 733,707 shares and have averaged 366,854 shares per transaction over this time period.
The number of insider buy/sell trades at ChromaDex is above the 188 peer company average over the last 90-day period. The Biotechnology & Medical Research peer group saw 199 buy/sell trades during this period for an average of 1.1 transactions per company. The number of shares per buy/sell trade for ChromaDex insiders was also higher. Within the peer group there were 23,505,504 shares purchased and 30,078,826 shares sold with company insiders disposing of 33,032 shares on average.
Insider buying and selling activity that is significant has been determined by eliminating all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers in evaluating and writing this story.
Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.
For more information, contact UpTick at email@example.com. Copyright 2017 UpTick Data Technologies. All rights reserved.